creatine semaglutide + Semaglutide: Safety & Clinical Considerations – PlexusDx Maximizing Health on GLP-1 Medications:

Second Natures peer-reviewed study published in JMIR Formative Research (2025) compared both medications within our programme: 3 Tirzepatide (Mounjaro) cohort (209 people): 22.1% average weight loss at 12 months 95.2% achieved at least 10% weight loss 83.7% achieved at least 15% weight loss Semaglutide (Wegovy) cohort (130 people): 17.1% average weight loss at 12 months 83.1% achieved at least 10% weight loss 56.2% achieved at least 15% weight loss Both cohorts exceeded clinical trial results, suggesting that comprehensive behavioural support enhances outcomes regardless of which medication you use

Most gastrointestinal side effects peak during the first 4-8 weeks and gradually improve as your body adapts

In case of a serious allergic reaction, call 999

Your physician will discuss the implications, risks, and benefits of compounded therapy at your consultation.

Or would they make my thyroid situation worse